These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 65771)

  • 1. [Role of hormonal factors in the pathogenesis of prostatic hypertrophy].
    Baranowska B; Migdalska B; Szymanowski J; Kozłowicz I
    Pol Tyg Lek; 1977 Feb; 32(6):251-3. PubMed ID: 65771
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
    Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common characteristics of human and canine benign prostatic hyperplasia.
    Isaacs JT
    Prog Clin Biol Res; 1984; 145():217-34. PubMed ID: 6201876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is the prostatic adenoma of hormonal origin].
    Bercovici JP; Morfin R; Charles JF
    Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the function of the hypothalamo-hypophyseal complex and gonads of patients with prostatic adenoma and cancer using the dexamethasone test].
    Portnoĭ AS; Ostroumova MN; Bobrov IuF; Dil'man VM
    Urol Nefrol (Mosk); 1984; (4):36-40. PubMed ID: 6206633
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate.
    Scarano WR; Vilamaior PS; Taboga SR
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Nov; 288(11):1190-200. PubMed ID: 17031809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and experimental studies of benign prostatic hyperplasia.
    Coffey DS; Walsh PC
    Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
    Magyarsóky F
    Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient hypertrophy of the ventral prostate and coagulating glands and accelerated thymic involution following pinealectomy in the mouse.
    Vaughan MK; Reiter RJ
    Tex Rep Biol Med; 1971; 29(4):579-86. PubMed ID: 4113015
    [No Abstract]   [Full Text] [Related]  

  • 10. Benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1976; 6():1-8. PubMed ID: 66685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of prostatic hyperplasia in normal and adenomatous glands of men and dogs: 3-alpha reduction of dihydrotestesterone].
    Jacob GH
    Endokrinologie; 1977 Oct; 70(2):158-68. PubMed ID: 73458
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T; Hashimoto Y; Takahashi K
    Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of tissue steroids in benign hyperplasia and prostate cancer].
    Voigt KD; Bartsch W
    Urologe A; 1987 Nov; 26(6):349-57. PubMed ID: 2448941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and hormonal milieu in ductal system of normal prostate and benign prostatic hyperplasia.
    Xia SJ; Xu CX; Tang XD; Wang WZ; Du DL
    Asian J Androl; 2001 Jun; 3(2):131-4. PubMed ID: 11404798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B; Zgliczyński S
    Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
    Horton R
    Am J Nephrol; 1982; 2(3):157-63. PubMed ID: 6184994
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in saliva and prostatic dihydrotestosterone levels.
    Boccon-Gibod L; Laudat MH; Guiban D; Steg A
    Eur Urol; 1988; 15(1-2):99-102. PubMed ID: 3215246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of growth factors in the pathogenesis of BPH.
    Habib FK
    Prog Clin Biol Res; 1994; 386():43-50. PubMed ID: 7528412
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathogenesis of BPH: role of hormones.
    Griffiths K; Eaton CL
    Prog Clin Biol Res; 1994; 386():33-41. PubMed ID: 7528401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.